Follow
Assay Development
Assay Development: one of the first steps in drug development and toxicity testing is creating test systems on which to evaluate the effects of chemical compounds on cellular, molecular or biochemical processes of interest.
What's Popular in Assay Development
-
NOV 19, 2024Clinical & Molecular DX
Neural interfaces create a direct link between the brain and a device like a computer to enable communication, and monit ...Written By: Carmen LeitchNOV 13, 2024Clinical & Molecular DX
Scientists developed a genetic tool that can quickly identify nearly any type of pathogenic infection, including those c ...Written By: Carmen LeitchNOV 10, 2024Clinical & Molecular DX
The FDA has a site where people can check the expiration dates, and potential extensions on those dates, for at-home COV ...Written By: Carmen LeitchNOV 06, 2024Clinical & Molecular DX
Neurodegenerative diseases of aging like Parkinson's disease (PD) or Alzheimer's disease (AD) are usually not di ...Written By: Carmen LeitchNOV 03, 2024Clinical & Molecular DX
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder in which neurons in the central nervous system that ...Written By: Carmen Leitch
NOV 19, 2024
Clinical & Molecular DX
Neural interfaces create a direct link between the brain and a device like a computer to enable communication, and monit
...
Written By:
Carmen Leitch
NOV 13, 2024
Clinical & Molecular DX
Scientists developed a genetic tool that can quickly identify nearly any type of pathogenic infection, including those c
...
Written By:
Carmen Leitch
NOV 10, 2024
Clinical & Molecular DX
The FDA has a site where people can check the expiration dates, and potential extensions on those dates, for at-home COV
...
Written By:
Carmen Leitch
NOV 06, 2024
Clinical & Molecular DX
Neurodegenerative diseases of aging like Parkinson's disease (PD) or Alzheimer's disease (AD) are usually not di
...
Written By:
Carmen Leitch
NOV 03, 2024
Clinical & Molecular DX
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder in which neurons in the central nervous system that
...
Written By:
Carmen Leitch
OCT 24, 2024
Clinical & Molecular DX
It's estimated that about 800,000 people have a heart attack every year in the United States alone. Heart attacks have t
...
Written By:
Carmen Leitch
OCT 20, 2024
Clinical & Molecular DX
Diabetes is a condition in which blood sugar is excessively high. It can be managed by checking blood sugar levels regul
...
Written By:
Carmen Leitch
OCT 14, 2024
Clinical & Molecular DX
This work is based on PET scan and genetic data that was collected from over 3,000 people.
Written By:
Carmen Leitch
OCT 02, 2024
Clinical & Molecular DX
The human genome contains many common features and characteristics beyond just being made of four bases. There are prote
...
Written By:
Carmen Leitch
-
APR 02, 2024 | 8:00 AM
Circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) have each gained attention as promising liquid biopsy markers, offering molecular insights into cancer progression, overall s...MAR 26, 2024 | 11:00 AM
Ever wonder what you’re missing in your data? The sheer complexity of today’s flow and mass cytometry datasets demands automated solutions. Machine learning plugins only provide...MAR 20, 2024 | 9:00 AMC.E. CREDITS
Join us in this enlightening session to deepen your understanding of qualifications and their transformative impact on risk management and regulatory adherence. Gain actionable insights that...Speaker: Danielle Wells, BS, MSPresented at: Guardians of Your Science, Ask the Expert Webinar Series
Sponsored By: Thermo Fisher ScientificMAR 20, 2024 | 8:00 AM
Luminex and Thermo Fisher Scientific are excited to feature two presentations highlighting the advanced features of the Invitrogen™ Luminex® xMAP® INTELLIFLEX™ DR-SE inst...FEB 15, 2024 | 8:00 AM
Macrophages can mediate phagocytosis of cancer cells and cytotoxic tumor killing, and engage in effective bidirectional interactions with components of the innate and adaptive immune system....
APR 02, 2024 | 8:00 AM
Circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) have each gained attention as promising liquid biopsy markers, offering molecular insights into cancer progression, overall s...
MAR 26, 2024 | 11:00 AM
Ever wonder what you’re missing in your data? The sheer complexity of today’s flow and mass cytometry datasets demands automated solutions. Machine learning plugins only provide...
MAR 20, 2024 | 9:00 AM
C.E. CREDITS
Join us in this enlightening session to deepen your understanding of qualifications and their transformative impact on risk management and regulatory adherence. Gain actionable insights that...
Speaker:
Danielle Wells, BS, MS
Presented at: Guardians of Your Science, Ask the Expert Webinar Series
Sponsored By: Thermo Fisher Scientific
Sponsored By: Thermo Fisher Scientific
MAR 20, 2024 | 8:00 AM
Luminex and Thermo Fisher Scientific are excited to feature two presentations highlighting the advanced features of the Invitrogen™ Luminex® xMAP® INTELLIFLEX™ DR-SE inst...
FEB 15, 2024 | 8:00 AM
Macrophages can mediate phagocytosis of cancer cells and cytotoxic tumor killing, and engage in effective bidirectional interactions with components of the innate and adaptive immune system....
FEB 08, 2024 | 10:00 AM
High-content screening (HCS) is an imaging-based, multi-parametric strategy used in drug development that generates rich datasets through multiplexing strategically chosen fluorescent dyes a...
JAN 31, 2024 | 10:00 AM
...
Speaker:
Matija Snuderl, MD
JAN 23, 2024 | 10:00 AM
Organoid technologies are increasingly being used as in vitro models of human development and disease because they exhibit morphogenetic, structural and functional properties that recapitula...
Speaker:
Kalpana Barnes
JAN 18, 2024 | 10:00 AM
In 2020, American Cancer Society released an updated cervical cancer screening guideline calling for primary human papillomavirus (HPV) screening as the preferred strategy. Utility of HPV pr...
-
C.E. CREDITS
Welcome to the Guardians of Science, Ask the Expert Webinar Series! Join our distinguished Thermo Fisher Scientific team of experts as they delve into the topics of advanced technology and pl...
Labroots is excited to announce the 16th Annual Event in the Clinical Diagnostics & Research Virtual Event Series taking place on November 12th, 2025! This event will again bring togethe...NOV 13, 2024 | 6:00 AM PSTC.E. CREDITS
Labroots is excited to announce the 15th Annual Event in the Clinical Diagnostics & Research Virtual Event Series! This event will again bring together clinicians, researchers, medical e...JAN 31, 2024 | 7:00 AM PST
This half-day virtual event welcomes industry scientists, government employees, and academic researchers interested in exploring the quickly evolving world of epigenetics! This 4-hr event, o...JAN 23, 2024 | 7:00 AM PST
More than 90% of therapeutic candidates fail to make it past phase III clinical trials, mainly due to the lack of adequate, advanced cell models to provide in-depth predictive insights that...
C.E. CREDITS
Welcome to the Guardians of Science, Ask the Expert Webinar Series! Join our distinguished Thermo Fisher Scientific team of experts as they delve into the topics of advanced technology and pl...
Labroots is excited to announce the 16th Annual Event in the Clinical Diagnostics & Research Virtual Event Series taking place on November 12th, 2025! This event will again bring togethe...
NOV 13, 2024
| 6:00 AM PST
C.E. CREDITS
Labroots is excited to announce the 15th Annual Event in the Clinical Diagnostics & Research Virtual Event Series! This event will again bring together clinicians, researchers, medical e...
JAN 31, 2024
| 7:00 AM PST
This half-day virtual event welcomes industry scientists, government employees, and academic researchers interested in exploring the quickly evolving world of epigenetics! This 4-hr event, o...
JAN 23, 2024
| 7:00 AM PST
More than 90% of therapeutic candidates fail to make it past phase III clinical trials, mainly due to the lack of adequate, advanced cell models to provide in-depth predictive insights that...
APR 18, 2024
C.E. CREDITS
Stago EdVantage Virtual University is an educational platform that demystifies hemostasis testing with on-demand webinars and a virtual exhibit hall that ......
NOV 08, 2023
| 5:30 AM PST
C.E. CREDITS
Labroots is pleased to announce the 14th Annual Event in the Clinical Diagnostics & Research Virtual Event Series to be held on November 9th, 2023 packed with featured speakers....
SEP 13, 2023
| 10:00 AM PDT
Liquid biopsy is an emerging area of clinical research, particularly in the context of cancer. As a minimally invasive complementary or alternative approach to tissue biopsies, liquid biopsi...
SEP 12, 2023
| 8:00 AM PDT
C.E. CREDITS
Tandem Mass Tags (TMT) have revolutionized the field of mass spectrometry by enabling simultaneous identification and quantification of protein expression from multiple samples in a single L...